Loading company…
Nuage Therapeutics discovers drugs targeting intrinsically disordered proteins.
Nuage Therapeutics develops drug discovery approaches targeting intrinsically disordered proteins, with an initial focus on aggressive cancers. Founded in 2021, the company is based in Barcelona and led by CEO Judit Folgueira, alongside co-founders Denes Hnisz, Mateusz Biesaga and Xavier Salvatella. In June 2023, it raised EUR 12.000 mn in Seed funding from Asabys Partners, Sofinnova Partners, Bstartup Banco Sabadell and the Center for Technological & Industrial Development.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in